Patient Affordability: The Ongoing Crisis and the Opportunities for Pharma - Archive

About Kantar Health

Kantar Health is a leading global healthcare consulting firm and trusted advisor to many of the world’s leading pharmaceutical, biotech, and medical device and diagnostic companies. It combines evidence-based research capabilities with deep scientific, therapeutic and clinical knowledge, commercial development know-how, and brand and marketing expertise to help clients evaluate opportunities, launch products and maintain brand and market leadership.

Kantar Health deeply understands the influence of patients, payers and physicians, especially as they relate to the performance and payment of medicines and the delivery of healthcare services. Its 700+ healthcare industry specialists work across the product lifecycle, from preclinical development to launch, acting as catalysts to successful decision-making in life sciences and helping clients prioritize their product development and portfolio activities, differentiate their brands and drive product success post-launch. For more information, please visit www.kantarhealth.com.

Patient Affordability: The Ongoing Crisis and the Opportunities for Pharma - Archive

In this webinar, Kantar Health examines patient affordability in cancer care, which is one of the leading non-clinical attributes in the oncologist’s decision to choose one therapeutic agent over another. Affordability will continue to grow in importance as insurance benefit designs shift greater cost burden. Financial assistance programs include a range of assistance sources that help patients afford their treatment.

Well-designed manufacturer-direct programs help keep prescriber decisions focused on clinical rather than financial considerations. Financial assistance programs are evolving and oncology practices place increasing value on them. Minimizing practice burden should be a key consideration in structuring program access, information, enrollment, and qualification. Developing strategies to support underinsured patients in the state exchanges will be essential to ensure continued access and adherence for this patient population.

Debbie Warner will be joined by Lynn Humphrey and Patricia Goldsmith on a panel that will share and discuss marketplace trends and provide perspectives from both oncology practices and charitable foundations that assist patients in need.

Watch the Webinar

Panelists:


Patricia Goldsmith
Patricia Goldsmith
Chief Executive Officer
CancerCare
Lynn Humphrey
Lynn Humphrey
Practice Manager
Cancer Center of Santa Barbara
Debbie Warner
Debbie Warner
Vice President, Oncology Commercial Strategies
Kantar Health

Moderated By:


Don Sharpe
Don Sharpe
President
OBR